Report Detail
Global and China Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2026
- RnM4181244 |
- 01 September, 2020 |
- Global |
- 140 Pages |
- QYResearch |
- Pharma & Healthcare
Nuclear Medicine/Radiopharmaceutic market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Segment by Application, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Diagnostic
Therapeutic
Regional and Country-level Analysis
The Nuclear Medicine/Radiopharmaceutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine/Radiopharmaceutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine/Radiopharmaceutic business, the date to enter into the Nuclear Medicine/Radiopharmaceutic market, Nuclear Medicine/Radiopharmaceutic product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
1 Study Coverage
- 1.1 Nuclear Medicine/Radiopharmaceutic Product Introduction
- 1.2 Market Segments
- 1.3 Key Nuclear Medicine/Radiopharmaceutic Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type
- 1.4.2 Tc-99
- 1.4.3 I-123/131
- 1.4.4 In-111
- 1.4.5 Xe-133
- 1.4.6 Th-201
- 1.4.7 Ga-67
- 1.4.8 Other
- 1.5 Market by Application
- 1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application
- 1.5.2 Diagnostic
- 1.5.3 Therapeutic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size, Estimates and Forecasts
- 2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2015-2026
- 2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026
- 2.2 Global Nuclear Medicine/Radiopharmaceutic, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Nuclear Medicine/Radiopharmaceutic Historical Market Size by Region (2015-2020)
- 2.3.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2021-2026)
- 2.4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2021-2026)
3 Global Nuclear Medicine/Radiopharmaceutic Competitor Landscape by Players
- 3.1 Global Top Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
- 3.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2015-2020)
- 3.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Nuclear Medicine/Radiopharmaceutic Manufacturers by Revenue
- 3.2.1 Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
- 3.2.5 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
- 3.4 Global Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
- 3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
- 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020)
- 4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020)
- 4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020)
- 4.1.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2026)
- 4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2021-2026)
- 4.2.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020)
- 5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020)
- 5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2015-2020)
- 5.1.3 Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
- 5.2 Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2026)
- 5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2015-2026
- 6.1.1 China Nuclear Medicine/Radiopharmaceutic Sales YoY Growth 2015-2026
- 6.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue YoY Growth 2015-2026
- 6.1.3 China Nuclear Medicine/Radiopharmaceutic Market Share in Global Market 2015-2026
- 6.2 China Nuclear Medicine/Radiopharmaceutic Market Size by Players (International and Local Players)
- 6.2.1 China Top Nuclear Medicine/Radiopharmaceutic Players by Sales (2015-2020)
- 6.2.2 China Top Nuclear Medicine/Radiopharmaceutic Players by Revenue (2015-2020)
- 6.3 China Nuclear Medicine/Radiopharmaceutic Historic Market Review by Type (2015-2020)
- 6.3.1 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
- 6.3.2 China Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2015-2020)
- 6.3.3 China Nuclear Medicine/Radiopharmaceutic Price by Type (2015-2020)
- 6.4 China Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2026)
- 6.4.2 China Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2021-2026)
- 6.4.3 China Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2021-2026)
- 6.5 China Nuclear Medicine/Radiopharmaceutic Historic Market Review by Application (2015-2020)
- 6.5.1 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
- 6.5.2 China Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
- 6.5.3 China Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
- 6.6 China Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2026)
- 6.6.2 China Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2021-2026)
- 6.6.3 China Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2015-2026
- 7.2 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
- 7.2.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020)
- 7.2.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2015-2026
- 8.2 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
- 8.2.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
- 8.2.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
- 9.2.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2015-2026
- 10.2 Latin America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
- 10.2.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
- 10.2.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
- 11.2.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 UAE
12 Company Profiles
- 12.1 GE Healthcare
- 12.1.1 GE Healthcare Corporation Information
- 12.1.2 GE Healthcare Description and Business Overview
- 12.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.1.5 GE Healthcare Recent Development
- 12.2 Bracco Imaging
- 12.2.1 Bracco Imaging Corporation Information
- 12.2.2 Bracco Imaging Description and Business Overview
- 12.2.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.2.5 Bracco Imaging Recent Development
- 12.3 Mallinckrodt
- 12.3.1 Mallinckrodt Corporation Information
- 12.3.2 Mallinckrodt Description and Business Overview
- 12.3.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.3.5 Mallinckrodt Recent Development
- 12.4 Lantheus Medical Imaging
- 12.4.1 Lantheus Medical Imaging Corporation Information
- 12.4.2 Lantheus Medical Imaging Description and Business Overview
- 12.4.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.4.5 Lantheus Medical Imaging Recent Development
- 12.5 Bayer
- 12.5.1 Bayer Corporation Information
- 12.5.2 Bayer Description and Business Overview
- 12.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.5.5 Bayer Recent Development
- 12.6 Jubilant Pharma
- 12.6.1 Jubilant Pharma Corporation Information
- 12.6.2 Jubilant Pharma Description and Business Overview
- 12.6.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.6.5 Jubilant Pharma Recent Development
- 12.7 Nordion
- 12.7.1 Nordion Corporation Information
- 12.7.2 Nordion Description and Business Overview
- 12.7.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.7.5 Nordion Recent Development
- 12.8 Eli Lilly
- 12.8.1 Eli Lilly Corporation Information
- 12.8.2 Eli Lilly Description and Business Overview
- 12.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.8.5 Eli Lilly Recent Development
- 12.9 SIEMENS
- 12.9.1 SIEMENS Corporation Information
- 12.9.2 SIEMENS Description and Business Overview
- 12.9.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.9.5 SIEMENS Recent Development
- 12.10 China Isotope & Radiation
- 12.10.1 China Isotope & Radiation Corporation Information
- 12.10.2 China Isotope & Radiation Description and Business Overview
- 12.10.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.10.5 China Isotope & Radiation Recent Development
- 12.11 GE Healthcare
- 12.11.1 GE Healthcare Corporation Information
- 12.11.2 GE Healthcare Description and Business Overview
- 12.11.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
- 12.11.5 GE Healthcare Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceutic Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Nuclear Medicine/Radiopharmaceutic Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Medicine/Radiopharmaceutic. Industry analysis & Market Report on Nuclear Medicine/Radiopharmaceutic is a syndicated market report, published as Global and China Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Nuclear Medicine/Radiopharmaceutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
